Tissue Factor Pathway Inhibitor Inhibits Endothelial Cell Proliferation via Association with the Very Low Density Lipoprotein Receptor
Open Access
- 1 April 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (15), 12241-12248
- https://doi.org/10.1074/jbc.m010395200
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Apolipoprotein(a), a Link between Atherosclerosis and Tumor AngiogenesisBiochemical and Biophysical Research Communications, 1999
- Interaction of Cytosolic Adaptor Proteins with Neuronal Apolipoprotein E Receptors and the Amyloid Precursor ProteinPublished by Elsevier BV ,1998
- The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor.JCI Insight, 1997
- The Endothelial Cell Protein C ReceptorPublished by Elsevier BV ,1996
- Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.JCI Insight, 1995
- The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I ComplexesPublished by Elsevier BV ,1995
- Apolipoprotein E: A potent inhibitor of endothelial and tumor cell proliferationJournal of Cellular Biochemistry, 1994
- Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23Somatic Cell and Molecular Genetics, 1993
- Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactionsNeuron, 1993
- The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin.The Journal of cell biology, 1990